Merck & Company, Inc. News Headlines

MRK 
$57.11
*  
0.97
1.67%
Get MRK Alerts
*Delayed - data as of Jul. 31, 2014 14:59 ET  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    MRK Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Must-know: Why Pfizer could up its offer for AstraZeneca
5/16/2014 9:00:00 AM - Market Realist

Chimerix Regains Worldwide Rights To CMX157 From Merck - Quick Facts
5/16/2014 8:17:00 AM - RTT News

Why the proposed Pfizer-AstraZeneca deal could face challenges
5/15/2014 1:00:00 PM - Market Realist

Bristol-Myers Squibb: The Stock Is Overpriced
5/15/2014 12:49:00 PM - Seeking Alpha

Why AstraZeneca’s oncology pipeline is attractive to Pfizer
5/15/2014 9:00:00 AM - Market Realist

Merck Continues to Divest Ophthalmology Products - Analyst Blog
5/14/2014 5:00:00 PM - Zacks.com

Dow Snaps Five-Day Winning Streak, S&P 500 Faces Resistance
5/14/2014 4:21:15 PM - Schaeffer's Investment Research

The 5 Most Overvalued Dow Stocks
5/14/2014 3:25:00 PM - Seeking Alpha

Despite Disappointing Performance, Pfizer Pins Its Hope On These Drugs
5/14/2014 1:48:22 PM - Trefis

Dow Movers: IBM, MRK
5/14/2014 11:50:45 AM - BNK Invest

Ablynx Q1 Loss Narrows - Quick Facts
5/14/2014 1:18:00 AM - RTT News

The must-know details of Pfizer’s offer to acquire AstraZeneca
5/13/2014 5:07:00 PM - Market Realist

Merck Sells Japan Eye-Treatment Rights
5/13/2014 10:35:00 AM - Fox Business

U.S. Hot Stocks: Hot Stocks to Watch
5/13/2014 9:26:00 AM - Dow Jones Business News

Merck to Sell Some Ophthalmology Assets
5/13/2014 7:25:00 AM - Dow Jones Business News

Merck Announces FDA Approval For ZONTIVITY - Quick Facts
5/12/2014 7:44:00 AM - RTT News

Tracking Irving Kahn's Kahn Brothers Portfolio - Q1 2014 Update
5/10/2014 6:37:00 AM - Seeking Alpha

After Hours Most Active for May 8, 2014 : LLY, BAC, QQQ, MSFT, ATML, RVT, MCP, SIRI, MRK, NEE^O, FB, OREX
5/8/2014 4:44:59 PM - NASDAQ.com News

Reversal of Fortune: Stocks Start Strong, Finish Weak
5/8/2014 4:17:34 PM - Schaeffer's Investment Research

Dow Movers: CVX, T
5/8/2014 12:20:16 PM - BNK Invest

Merck Plans Phase 3 Trial for Drug for Bone Marrow Transplant Patients
5/8/2014 9:55:00 AM - Dow Jones Business News

Time To Be Overweight On Merck - Multiple Catalysts On The Horizon
5/8/2014 4:35:00 AM - Seeking Alpha

Bayer to Purchase Merck's Consumer Division - Analyst Blog
5/7/2014 3:35:01 PM - Zacks.com

Merck Banks On R&D Pipeline And Immunology Drugs As Pricing Pressure Grows
5/7/2014 1:50:51 PM - Trefis

Dow Movers: MRK, TRV
5/7/2014 12:02:56 PM - BNK Invest